The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $132.40

Today's change-0.34 -0.26%
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $132.40

Today's change-0.34 -0.26%
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings down (U.S.)$0.34

Laboratory Corporation of America Holdings closed lower Friday, dropping (U.S.)$0.34 or 0.26% to (U.S.)$132.40. Shares have lost 1.44% for the last five days, but have gained 20.70% over the last 52 weeks. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $132.93
  • Previous close(U.S.) $132.74
  • High(U.S.) $133.42
  • Low(U.S.) $131.93
  • Bid / Ask-- / --
  • YTD % change+3.13%
  • Volume525,795
  • Average volume (10-day)773,122
  • Average volume (1-month)702,440
  • Average volume (3-month)732,667
  • 52-week range(U.S.) $97.79 to (U.S.) $141.32
  • Beta0.94
  • Trailing P/E20.89×
  • P/E 1 year forward15.03×
  • Forward PEG1.47×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $6.34
Updated January 20 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.97%

Based on its net profit margin of 6.97%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.90%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue2,4152,4312,3682,301
Total other revenue--------
Total revenue2,4152,4312,3682,301
Gross profit788827777741
Total cost of revenue1,6261,6041,5911,560
Total operating expense2,0912,0642,0662,057
Selling / general / administrative401408412405
Research & development--------
Depreciation / amortization41454438
Interest expense (income), net operating--------
Unusual expense (income)2371954
Other operating expenses, total--------
Operating income324367302243
Interest income (expense), net non-operating-58-54-55-57
Gain (loss) on sale of assets--------
Other--------
Income before tax263313256186
Income after tax180199161115
Income tax, total841159672
Net income180198160114
Total adjustments to net income--------
Net income before extra. items180198160114
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items180198160114
Inc. avail. to common incl. extra. items180198160114
Diluted net income180198160114
Dilution adjustment----0--
Diluted weighted average shares105104104103
Diluted EPS excluding extraordinary itemsvalue per share1.711.911.551.11
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.861.951.661.43